Ocean Biomedical, Inc. (OCEA): Nasdaq/NYSE listing notice — Ocean Biomedical receives Nasdaq delisting affirmation; shares to be suspended

Ocean Biomedical, Inc.

Listing Council affirms Nasdaq's decision to delist Ocean Biomedical securities, effective April 24, 2025.
Company had appealed the Panel's April 22, 2025 delisting decision, but the appeal was denied.
Trading suspension to begin at opening of business on April 24, 2025.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Ocean Biomedical, Inc. received a nasdaq delisting notice notice.

Exchange: nasdaq
Notice: delisting notice

Exact text from the filing

April 22, 2025, the Nasdaq Hearings Panel (the “Panel”) issued a decision to delist the Company’s securities from The Nasdaq Stock Market, LLC (the “Exchange” or “Nasdaq”) and suspend trading of the Company’s shares, effective at the opening of business on April 24, 2025. The Company appealed the Panel’s decision to the Listing Council. After considering the written record in this matter, the Listing Council affirms the Panel’s decision to delist the Company from the Nasdaq affirming Nasdaq’s delist decision letter dated April 22, 2025. SIGNATURE Pursuant to the requirements of the Securities

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-020730

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.